Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 35.05
+0.05 (0.14%)
May 8, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 14.22 billion as of May 8, 2026. Its market cap has increased by 161.42% in one year.
Market Cap
14.22B
Enterprise Value
14.46B
Revenue
774.47M
Ranking
n/a
PE Ratio
251.22
Stock Price
35.05
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 14.22B, a decrease of -12.06%. That is a compound annual growth rate of -2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.22B | 38.13% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinyu Bio-technology | 16.25B |
| Mabwell (Shanghai) Bioscience | 15.26B |
| Anhui Anke Biotechnology (Group) | 14.65B |
| Chengzhi | 13.95B |
| Staidson (Beijing) BioPharmaceuticals | 13.69B |
| Inner Mongolia Furui Medical Science | 13.62B |
| Tibet Cheezheng Tibetan Medicine | 13.08B |
| InventisBio | 12.72B |